Dermatology Medical News about Sporotrichosis Potassium Iodide

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Oral potassium iodide for the treatment of sporotrichosis
Cochrane Reviews, 10/26/09

Xue S et al. – Potassium iodide is an anti–fungal drug listed in the World Health Organization (WHO) essential drug list and generally thought to be the first choice for cutaneous sporotrichosis including fixed and lymphocutaneous types, in developing countries. No randomised controlled trials (RCTs) of oral potassium iodide versus placebo were found and thus its efficacy and safety could not be analysed in this review. There is a need for randomised placebo controlled trials of oral potassium iodide in this area.

<< Previous
A randomized controlled trial in children with eczema: nurse...

Next >>
Late-onset of IgE sensitization to microbial allergens in young...

Multiple Subcutaneous Mycetomas caused by Pseudallescheria boydii: Response to therapy with oral potassium iodide solution
Journal of Infection, 10/12/09 Relevance Score: 66%

Zoonotic sporotrichosis of lymphocutaneous type in a man acquired from a domesticated feline source: report of a first case in southern Karnataka, India
International Journal of Dermatology, 10/30/09 Relevance Score: 43%

Terbinafine (250 mg/day): an effective and safe treatment of cutaneous sporotrichosis
Journal of the European Academy of Dermatology and Venereology, 10/26/09 Relevance Score: 43%

Effect of Potassium Citrate Therapy on the Risk of Renal Stone Formation During Spaceflight
The Journal of Urology, 10/22/09 Relevance Score: 43%

Iodide protects hyaluronate from oxidative stress
Spektrum der Augenheilkunde, 10/01/09 Relevance Score: 43%